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ABSTRACT: Controlled enzyme dehydration using a new processing technique of MicroglassificationTM has been investigated. Aqueous
solution microdroplets of lysozyme, -chymotrypsin, catalase, and horseradish peroxidase were dehydrated in n-pentanol, n-octanol,
n-decanol, triacetin, or butyl lactate, and changes in their structure and function were analyzed upon rehydration. Water solubility and
microdroplet dissolution rate in each solvent decreased in the order: butyl lactate > n-pentanol > triacetin > n-octanol > n-decanol.
EnzymesMicroglassifiedTM in n-pentanol retained higher activity (93%–98%) than n-octanol (78%–85%) or n-decanol (75%–89%), whereas
those MicroglassifiedTM in triacetin (36%–75%) and butyl lactate (48%–79%) retained markedly lower activity. FTIR spectroscopy analyses
showed -helix to -sheet transformation for all enzymes upon MicroglassificationTM, reflecting a loss of bound water in the dried state;
however, the enzymes reverted to native-like conformation upon rehydration. Accelerated stressed-storage tests using MicroglassifiedTM
lysozyme showed a significant (p < 0.01) decrease in enzymatic activity from 46,560 ± 2736 to 31,060 ± 4327 units/mg after 3 months
of incubation; however, it was comparable to the activity of the lyophilized formulation throughout the test period. These results establish
MicroglassificationTM as a viable technique for enzyme preservation without affecting its structure or function. C© 2014 Wiley Periodicals,
Inc. and the American Pharmacists Association J Pharm Sci
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INTRODUCTION
The development of enzyme formulations that are stable dur-
ing shipping and long-term storage is one of themost important
considerations in developing enzymes as commercial products.1
The chemical complexity and marginal stability of higher order
or multi domain protein structure often presents significant
stability problems.2 For ease of preparation and handling, liq-
uid preparations are generally preferred. However, the pres-
ence of water in liquid preparations has the potential to en-
courage structural changes or even serve as a reactant for
chemical degradation.3 Stress conditions in liquid media, such
as heating and freezing, shaking, pH variations, and changes
in amino acid side-chain structures may result in undesirable
by-products and compromised functionality.4,5 Shear forces as-
sociated with mechanical shaking can partition proteins to the
air–water interface and thus expose them to degrading interfa-
cial tensions. Gidalevitz et al.4 studied the behavior of glucose
oxidase, alcohol dehydrogenase, and urease, and found that the
exposure of enzymes to such tensions and the more hydropho-
bic air phase encouraged partial unfolding. Variations in liquid
media pH can change the oxidation potential of oxidants, al-
ter the binding affinity between the catalytic metal ions and
ionizable amino acids, and modify the stability of the oxida-
tion intermediates.5 Therefore, when the inherent stability and
function of the protein, or the economics and logistics of product
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shipping (e.g., maintaining a cold chain) and use (e.g., loss of
soluble protein because of surface or interfacial adsorption) pre-
clude storage in the liquid form, the protein product is generally
dried and stored in a solid form.6 Traditional drying methods
are often accompanied by a modification in the product’s ther-
mal history, which may impact thermo-mechanical properties,
such as diffusivity and stability, as well as product quality or
activity.7 Enzymes such as lysozyme and catalase undergo an
irreversible loss in activity when freeze-dried in the absence of
excipients, with activity losses of up to ∼7% for lysozyme and
35%–50% for catalase.8 In the food processing industry, spray
drying of whey proteins has been known to result in partial de-
naturation and increased insolubility of the dried product, even
at modest outlet temperatures of 60◦C.9,10 Freeze drying lignin
peroxidase, an enzyme used in degradation of lignin in wood,
has been shown to result in ∼30% loss of activity, although the
inclusion of sucrose improved activity retention.11 Lyophiliza-
tion and spray drying methods have been very well developed
and customized within the pharmaceutical industry; the use of
excipients and stabilizers in therapeutic protein formulations
have generally been very successful in minimizing loss in func-
tional activity.1,12 Nevertheless, challenges remain in address-
ing the dehydration of complex biologics, such as recombinant
human interferon-(, which is prone to aggregation induced, in
part, because of adsorption at air–liquid and solid–air inter-
faces during the drying procedure.13,14 Therefore, a successful
drying technique should be able to minimize process dependent
stresses such as thermal, mechanical, interfacial adsorption,
and pressure induced instability without irreversible changes
to enzyme function.15
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The presence of water in the surrounding microenvironment
of most globular proteins enhances its conformational freedom
needed to relieve stresses imposed by dynamic structural and
environmental changes involving temperature, salt concentra-
tion, or addition of hydrophobic interfaces.7,16 The removal of
the surrounding water, in particular, the partial removal of
water of hydration, can improve protein storage and stabil-
ity by restricting intra-domain mobility and alleviating water-
dependent physicochemical degradation pathways. The loss of
enzyme functionality is a two-step phenomenon that involves
reversible unfolding followed by kinetically irreversible steps
that may lead to aggregation or covalent structural changes.17
We have recently reported that a new dehydration technol-
ogy, called MicroglassificationTM, can controllably remove wa-
ter from proteins leading to rapid solidification at ambient
temperature.18 Studies on single lysozyme microdroplet dehy-
dration have shown that by adjusting the water activity of an
organic medium, such as n-decanol, the microdroplet can be
dehydrated to sub-monolayer hydration levels in the form of a
solidmicrosphere having a concentration of 700–1150mg/mL.19
Globular proteins, such as bovine serum albumin (BSA) can
be similarly dehydrated to sub-monolayer water coverage with
concomitant and reversible structural changes upon rehydra-
tion and only minor levels of irreversible aggregation.18 In
this work, we report the continued evaluation and optimiza-
tion of MicroglassificationTM on a series of enzymes: lysozyme,
"-chymotrypsin, catalase, and horseradish peroxidase (HRP),
using a range of dehydrating solvents. The enzymatic activity
of each of the MicroglassifiedTM enzymes has been analyzed
upon rehydration and compared with the activity of a commer-
cially available lyophilized formulation. Moreover, comprehen-
sive analyses of the effect of MicroglassificationTM on enzyme
secondary structure have been carried out using Fourier trans-
form infrared spectroscopy (FTIR). In a preliminary study, we
have also performed accelerated storage tests to evaluate the
effect of stressed storage conditions on the structure and func-
tion of MicroglassifiedTM lysozyme powder.
MATERIALS AND METHODS
Materials
All reagents and enzymes including chicken egg white
lysozyme, bovine pancreas "-chymotrypsin, bovine liver cata-
lase, and HRPwere purchased in lyophilized form from Sigma–
Aldrich (St. Louis, Missouri). The solvents n-pentanol, n-
octanol, n-decanol, triacetin, and butyl lactate were used as
received without further purification. Enzyme solutions were
obtained by dissolving the lyophilized samples in phosphate
buffer saline.
Water Solubility in Organic Phase
Prior to dehydrating the protein microdroplets, it is necessary
tomeasure the solubility of water in the dehydrating solvents in
order to determine water-saturation levels and fractional water
saturation (f). The f value represents the ratio of the experimen-
tal water concentration to saturated water concentration in a
particular solvent and thus establishes the correlation between
the water removal and its chemical potential. Water solubility
was measured and verified using two independent techniques:
Refractive index method and Karl Fischer titration.
Refractive Index Method
A series of standard solutions (water-in-solvent) of the drying
solvents were prepared by mixing the drying solvent with DI
water (0–100 mg/mL). The solution was allowed to equilibrate
at room temperature (23◦C) for 24 h and its refractive indexwas
measured in triplicate using a digital DR-A1 Abbe refractome-
ter (Atago, Bellevue, Washington). The refractive indices were
adjusted to the corresponding value at 22◦C using the equation:
n22 = nx − 0.00045 (Tx – 22), where nx is the refractive index
of the solution at temperature Tx.20 The refractive index val-
ues were plotted against water concentration in that solvent,
and the refractive indices of the solvent, which were partially
saturated (one phase), were fit to a second-order polynomial
trend line. The intersection of this trend line with the average
refractive index of the fully saturated solvent (two phases) was
taken to be the solubility limit of water in that drying solvent.
Karl Fisher Titration
The water content of the saturated solvent/water mixtures
was measured by Karl Fisher titration using Aquastar AQC34
coulometer (Mettler Toledo, Columbus, Ohio). A 0.05–0.10 g
sample of the solvent-rich phase was titrated against Aquastar
CombiCoulomat fritless reagent (n = 5), and the water content
was reported in units of (g water/ 100 g solution).
To compare the enzyme hydration in different solvents, it is
important to correlate water activity (aw) to fractional water
saturation (f) value. For the solvents used in this study, such
correlations have already been reported for n-pentanol and n-
decanol by our group,18 and for n-octanol by Segatin et al.21 The
aw of water–triacetin and water–butyl lactate solutions were
set between 0.11 and 0.90 by saturated salt solutions using
previously described isopiestic protocols18 and equilibrated for
1 month at 22◦C. The water content of the partially saturated
triacetin or butyl lactate phase corresponding to each aw was
determined by Karl Fischer titration (n = 5).
Single Microdroplet Dissolution
A micropipette consisting of a single tapered glass capillary
with a tip diameter of 4–10 :mwas employed to study the disso-
lution of a single water droplet in each drying solvent. Following
the methods established in our laboratory,22,23 the micropipette
was mounted upon a micromanipulation system attached to a
microscope equipped with a digital camera. The advantage of
this setup is that it permits the manipulation of single pure-
aqueous24 or aqueous protein solution microdroplets,19,23 or gas
micro-bubbles22 of the fluid, which are typically tens of microns
in diameter. Because each of the solvents in this study was
mutually soluble with, but not miscible in, water, it was possi-
ble to clearly define an observable water–solvent interface. In
separate experiments, single ∼80-:m diameter water micro-
droplets were expelled in each of the organic phases and the
time-dependent dissolution of the droplets was recorded. The
time required for complete droplet dissolutionwas calculated by
extrapolating the droplet diameter to zero. The diffusion coeffi-
cient of water in the drying solvent was calculated as described
by Su et al.23
Enzyme MicroglassificationTM
MicroglassificationTM of each enzyme was carried out by creat-
ing a water-in-oil emulsion of each enzyme solution (20 mg/mL)
with 1.5 mL of the dehydrating medium in a microcentrifuge
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tube. The volume of the enzyme solution to be added was ad-
justed to achieve a final f value of 0.5, based on our previous
experience that most of the water from the protein can be re-
moved at this condition.18,19 The volume of enzyme solution,Vw,
was calculated according to: Vw = f × Vs × Cs × D, where f is the
desired water saturation fraction, Vs is the volume of solvent,
Cs is the solubility of water in the solvent (g water/g solvent),
and D is the density of the solvent. Based on the solubility limit
of each solvent (see results), 24, 32, 52, 70, and 117 :L of the
enzyme solution was added to 1.5 mL of n-decanol, n-octanol,
triacetin, n-pentanol, and butyl lactate, respectively. As a rep-
resentative calculation, 70 :L of enzyme solution was added to
1.5 mL of n-pentanol, which has a density of 0.811 g/cm3 and
water solubility of 11.43 gwater/100 g n-pentanol (equivalent to
10.31 g water/100 g solution), to achieve f of 0.5. The emulsion
was vortexed at 10,000 rpm for 5 min leading to the forma-
tion of MicroglassifiedTM beads. The supernatant was removed,
and the MicroglassifiedTM product was rinsed with ethanol to
remove any remaining solvent and vacuum dried overnight in
a desiccator over drierite (W.A. Hammond Drierite Company
Ltd., Xenia, Ohio).
Particle Size Distribution
To analyze particle size distribution, a 20 :L drop of
1 wt%MicroglassifiedTM particles suspended in n-pentanol was
mounted on a clean glass slide and covered with a cover-slip.
Multiple images were acquired from 20 random regions (∼3000
particles) using a Nikon Diaphot 200 (Nikon, Melville, New
York) optical microscope equipped with a 40× objective. The
particle size was measured by image analyses using the Im-
ageJ program (http://rsb.info.nih.gov/ij/index.html), and their
frequency distribution in the size ranges of 0–5, 5–10, and
>10 :m was determined.
Measurements of Enzyme Activity
Lysozyme
The activity assay for lysozyme measures the rate at
which the enzyme lyses intact Micrococcus lysodeikticus cells.
MicroglassifiedTM and lyophilized lysozyme samples (n = 5)
were dissolved in 0.1 M phosphate buffer (pH 6.24) and then
diluted to 0.025 mg/mL. A 100 :L volume of the test sample
was added to 2.6 mL of a 0.15 mg/mL solution of M. lysodeik-
ticus cells in phosphate buffer. The decrease in solution ab-
sorbance was measured at 450 nm for 3 min at 25◦C using
a UV–Vis spectrophotometer (Shimadzu UV-1601, Shimadzu
Corporation, Columbia, Maryland). The enzyme activity was
based on the premise that one unit of lysozyme produces a
change of 0.001 absorbance units per minute in a suspension of
M. lysodeikticus cells (substrate) at 450 nm in a 2.6 mL reaction
mixture at pH 6.24 and 25◦C.24
-Chymotrypsin
MicroglassifiedTM and lyophilized "-chymotrypsin samples (n
= 5) were dissolved in 1 mM cold HCl at a concentration of
100 :g/mL. A 100 :L test solution was mixed with 1.42 mL of
80 mM tris buffer (pH 7.8), 1.40 mL of 1.8 mM N-benzoyl-L-
tyrosine ethyl ether (BTEE) substrate, and 80 :L of 2 M CaCl2.
The increase in absorbance resulting from the breakdown of
BTEE into N-benzoyl-L-tyrosine and ethanol was monitored at
256 nm. The determination of the enzyme activity was based on
the premise that one unit "-chymotrypsin hydrolyzes 1.0 :mol
BTEE per min at pH 7.8 in a 3.0 mL reaction mixture at 25◦C.25
Catalase
MicroglassifiedTM and lyophilized catalase samples (n= 5) were
rehydrated in 50 :M phosphate buffer (pH 7.0) at a concentra-
tion of 1.0 mg/mL and then diluted to 25 :g/mL. 100 :L test
solution was added to 2.9 mL of buffer followed by 5 :L of 30%
H2O2 solution. The contents were mixed by inversion and the
rate of change of absorbance was monitored at 240 nm. The
activity for catalase was determined on the premise that one
unit catalase decomposes 1.0 :mol of H2O2 per min at pH 7.0
in a 3.0 mL reaction mixture at 25◦C.26
Horseradish Peroxidase
MicroglassifiedTM and lyophilized HRP samples (n = 5) were
dissolved in 0.1 M phosphate buffer (pH 6.0) at a concentration
of 100 :g/mL. A 100 :L test solution was added to 160 :L of
50% H2O2, 2.10 mL of DI water, and 320 :L each of phosphate
buffer and pyrogallol (substrate). The contents were mixed by
inversion at 20◦C and the enzymatic conversion of pyrogallol
to purpurogallin was monitored at 420 nm. The determination
of the enzyme activity was based on the premise that one unit
HRP forms 1.0 mg of purpurogallin from pyrogallol in 20 s at
pH 6.0 in a 3.0 mL reaction mixture at 20◦C.27
Protein Concentration
To normalize the enzymatic activity, the total protein content of
each samplewas determined using the bicinchoninic acid (BCA)
assay according to the manufacturer’s instructions (Thermo
Scientific, Rockford, Illinois). Known concentrations of BSA
served as standards.
Analyses of Enzyme Secondary Structure
The secondary structure of both dried and rehydrated
MicroglassifiedTM enzymes (n = 5) was analyzed by FTIR using
FTLA2000 spectrometer (ABB, Wickliffe, Ohio) equipped with
a diamond crystal attenuated total reflectance (ATR) acces-
sory. Samples were rehydrated at a concentration of 50 mg/mL.
Lyophilized enzyme formulations, both dried and rehydrated,
served as controls. For each sample, a 200-scan interferogram
was collected at a resolution of 4 cm−1 using an empty cell as the
background. The spectra of the sample buffer were subtracted
from the spectra of the rehydrated samples using PROTA soft-
ware package implemented within Bomem-GRAMS/32 AI. The
baseline of the spectra was adjusted from 1460 to 1720 cm−1 to
accommodate the amide I and amide II regions. A combination
of Fourier self-deconvolution (FSD), second derivatization, and
curve fitting algorithms were employed to elucidate enzyme
secondary structure, as described by Dong et al.28 Briefly, res-
olution enhancement of the original spectra was carried out in
the amide I region (1600–1700 cm−1) by FSD at an enhance-
ment factor of 2.6. The secondary derivatives of the deconvo-
luted spectra were obtained, baseline corrected, inverted, and
smoothed using seven-point Savitsky–Golay function. The re-
solved spectra were fitted to a Gaussian curve profile and the
peaks were assigned as per the convention described in the
literature.29 The relative area of each of the resolved peaks was
used for quantitative analyses.
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Accelerated Storage Test
The effect of stressed storage conditions on enzyme activity
and structure was evaluated for lysozyme as a representa-
tive model. We realize that real-time stability studies are ob-
viously the most reliable demonstration of a product’s shelf
life, and accelerated storage testing, based on the Arrhenius
equation, is a practical means of quality assurance for biologi-
cal standards.30,31 However, we chose to use a simpler test for
preliminary analysis, which has been previously described in
the literature.32,33 Briefly, ∼30 mg of dried MicroglassifiedTM
lysozyme prepared in n-pentanol was aliquoted in glass vials
and secured with rubber-lined plastic caps. The lyophilized
lysozyme samples served as control. The samples were stored at
40◦C for 3 months in a hot air oven (n = 3/time-point), and the
enzyme activity and secondary structure of the powders were
analyzed at the end of each month using the methods described
earlier. Although the exact level of hydration of these samples
was not determined, both theMicroglassifiedTM and lyophilized
samples were stored under vacuum prior to sealing the vials.
We have previously shown thatMicroglassifiedTM lysozyme and
lyophilized lysozyme powders absorb the same amount of wa-
ter as a function of water activity,19 so it is assumed that both
samples had the same low level of residual moisture.
Statistical Analyses
Where appropriate, the data were expressed as themeans± SD
and analyzed statistically by one-way ANOVA using Tukey’s
post-hoc test. A p value <0.05 was considered statistically sig-
nificant.
RESULTS
Water Solubility Limit and Dehydration Rate
Figure 1 shows the variation in refractive index of the water–
n-pentanol system with increasing water concentration. A
second-order polynomial trend-line was fit to the data repre-
senting the single-phase system, and its intersection with the
average of the two-phase system represents the solubility limit
of water in n-pentanol. Note that this slightly nonlinear trend
for refractive index versus water concentration is in agreement
with other measures of the same property for isomeric pentanol
in water.34 The solubility limit of water in n-pentanol was found
to be 11.43 g water/100 g n-pentanol, which corresponds to
10.31 g water/100 g solution. The solubility limit values calcu-
lated using refractive index andKarl Fischer titrationmethods,
and the diffusion coefficient of water in each solvent are shown
in Table 1. The diffusion coefficient of water in n-pentanol and
n-octanol has been previously reported by Su et al.23 Over-
all, our results show that in the alcohol homologous series, an
increase in the chain length of the primary alkyl-alcohols de-
creases their water solubility limit. We have included literature
values for the solubility limit,35,36 solvent’s refractive index,37
and dielectric constant37—which will be used in discussing the
dehydration mechanism. Figure 2 shows the microdroplet dis-
solution curves for 80-:m diameter water droplets for each of
the drying solvents tested. It was found that the solubility of
water as well as the initial water dissolution rate in the dry-
ing media decreased in the order: butyl lactate > n-pentanol >
triacetin > n-octanol > n-decanol; time required for complete
dissolution of such an 80-:mdiameter water microdroplet were
Figure 1. The variation of refractive index of water–n-pentanol sys-
tem with increasing concentration of water in n-pentanol. The refrac-
tive index of the partially saturated n-pentanol (one phase) was fit to a
second-order polynomial trend line, and the intersection of this trend
line with the average refractive index of the fully saturated n-pentanol
(two phases) was taken to be the solubility limit of water in n-pentanol.
Similar curves were constructed for all the solvents in this study.
17, 24, 38, 114, and 202 s, respectively. The aw values for n-
pentanol, n-octanol, n-decanol, triacetin, and butyl lactate for
MicroglassificationTM conditions (f = 0.5) were 0.82,18 0.74,21
0.75,18 0.85, and 0.85, respectively.
Particle Size Distribution
Figure 3 shows the particle size distribution of the
MicroglassifiedTM enzyme beads in n-pentanol. It was found
that just less than half (47%, 43%, 45%, and 46%) of the
MicroglassifiedTM lysozyme, "-chymotrypsin, catalase, and
HRP particles were in the size range of 5–10 :m, respec-
tively. About one third (28%, 31%, 26%, and 27%) were in
the size range of 0–5 :m, whereas the remainder of the
MicroglassifiedTM particles of each enzyme (25%, 26%, 29%,
and 27%) was >10 :m in size.
Enzyme Activity
Enzymatic activity assays of MicroglassifiedTM lysozyme,
"-chymotrypsin, catalase, and HRP upon reconstitution
in buffer are shown in Figure 4. In general, enzymes
MicroglassifiedTM in primary alkyl-alcohols, particularly in n-
pentanol, demonstrated higher activity upon reconstitution
than those MicroglassifiedTM in triacetin or butyl lactate. The
activities have been normalized to total protein content and
also expressed as percentage of lyophilized control.
Lysozyme
The average enzyme activity of rehydrated lysozyme decreased
in the series: control > n-pentanol > n-octanol > n-decanol >
triacetin > butyl lactate (Fig. 4a). Samples MicroglassifiedTM
in n-pentanol (46,560 ± 2736 units/mg; 94%), n-octanol (42,061
± 4207 units/mg; 85%), n-decanol (41,323 ± 4811 units/mg;
84%), or triacetin (40,585 ± 2609 units/mg; 82%) demonstrated
Aniket et al., JOURNAL OF PHARMACEUTICAL SCIENCES DOI 10.1002/jps.24279
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Table 1. Table Showing the Measured Values of the Solubility Limit and Diffusion Coefficient of Water in Various Organic Solvents
Measured Water Solubility
(g Water/100 g Solution) (22◦C)
RI Karl Published Water Solubility Refractive Dielectric Diffusion
Solvent Method Fischer (g Water/100 g Solution) Index (20◦C) Constant Coefficient (cm2/s)
n-Pentanol 10.31 ± 0.02 10.79 ± 0.02 10.21 (Ref. 35) 1.410 15.1 0.52 × 10− 5 (Ref. 23)
n-Octanol 4.83 ± 0.04 4.82 ± 0.08 4.35 (Ref. 35) 1.429 10.3 0.20 × 10− 5 (Ref. 23)
n-Decanol 3.63 ± 0.07 3.78 ± 0.03 3.68 (Ref. 36) 1.437 8.1 0.97 × 10− 6
Triacetin 4.15 ± 0.05 4.56 ± 0.14 – 1.430 7.1 0.36 × 10− 5
Butyl lactate 15.88 ± 0.04 15.23 ± 0.24 – 1.421 5.1 0.30 × 10− 5
The refractive index and dielectric constant values have been adopted from Landolt–Bornstein tables.37
Figure 2. Measurement of the dissolution rate of a water droplet in
the organic solvent. The time required for the complete dissolution of an
80 :m diameter water microdroplet held on the end of a micropipette
in an organic solvent increased in the order: butyl lactate < n-pentanol
< triacetin < n-octanol < n-decanol.
comparable activity to the control (49,440 ± 6703 units/mg;
100%). Samples MicroglassifiedTM in butyl lactate (39,109 ±
3300 units/mg; 79%) showed significantly lower (p < 0.05) ac-
tivity than the control.
-Chymotrypsin
The activity data for "-chymotrypsin displayed a similar trend
to that of lysozyme. As shown in Figure 4b, chymotrypsin
activity measured for the enzyme solutions that had been
MicroglassifiedTM in n-pentanol (44 ± 3 units/mg; 96%), n-
octanol (42 ± 2 units/mg; 91%), or n-decanol (39 ± 5 units/mg;
85%) was comparable to the control (46 ± 7 units/mg; 100%).
On the other hand, samples MicroglassifiedTM in triacetin (34
± 4 units/mg; 75%) or butyl lactate (31± 3 units/mg; 67%) were
significantly lower (p < 0.05) than the control.
Catalase
The overall trend for enzymatic activity of catalase samples was
similar to lysozyme and "-chymotrypsin; however, only sam-
ples MicroglassifiedTM in n-pentanol (14,451 ± 973 units/mg;
93%) were comparable to the control (15,551 ± 1235 units/mg;
100%) as shown in Figure 4c. Samples MicroglassifiedTM
in n-octanol (12,165 ± 1314 units/mg; 78%), n-decanol
(11,581 ± 1200 units/mg; 75%), or triacetin (10,563 ±
Figure 3. Particle size distribution of MicroglassifiedTM enzyme
beads. The size fraction was similar across all the enzymes.
470 units/mg; 68%) showed significantly lower (p < 0.05) activ-
ity than the control. Samples MicroglassifiedTM in butyl lactate
(7854 ± 750 units/mg; 51%) exhibited significantly lower activ-
ity than the control (p < 0.01) or any of the other solvents (p <
0.05).
Horseradish Peroxidase
The enzymatic activity of rehydrated HRP samples showed
mixed results. As shown in Figure 4d, samples that had been
MicroglassifiedTM in n-pentanol (241 ± 36 units/mg; 98%),
n-octanol (210 ± 47 units/mg; 85%), or n-decanol (219 ±
33 units/mg; 89%) were comparable to the control (246 ±
25 units/mg; 100%). In contrast, samples MicroglassifiedTM in
either triacetin (89 ± 27 units/mg; 36%) or butyl lactate (118 ±
24 units/mg; 48%) exhibited a very significant reduction
(p < 0.01) in activity as compared with the samples
MicroglassifiedTM in other solvents or the control.
Structural Analyses of MicroglassifiedTM Enzymes
A combination of FSD, secondary derivatives, and curve-fitting
algorithms were used on the FTIR spectra to determine the
secondary structure of the MicroglassifiedTM enzymes. The sec-
ondary structures of dehydrated enzyme powders (lyophilized
control and MicroglassifiedTM samples) are shown in Table 2
and upon rehydration in buffer in Table 3.
DOI 10.1002/jps.24279 Aniket et al., JOURNAL OF PHARMACEUTICAL SCIENCES
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Figure 4. Enzymatic assays of microglassified (a) lysozyme, (b) "-chymotrypsin, (c) catalase, and (d) HRP, showing the recovery of enzymatic
activity upon rehydration. Commercially available lyophilized enzymes were used as control. (*p < 0.05), (**p < 0.01).
Lysozyme
MicroglassifiedTM Powder. The amide I peak center of all
MicroglassifiedTM and lyophilized lysozyme samples occurred
at 1648 cm−1. Overall, it was found that the secondary struc-
ture of MicroglassifiedTM enzyme prepared in each solvent
was comparable to the secondary structure of the lyophilized
sample (Table 2), and were consistent with previously pub-
lished literature values for the lyophilized formulation38,39
("-helix: 22%–27%; $-sheet: 21%–23%; others 33%–51%). As
a representative example, lysozyme MicroglassifiedTM in n-
pentanol was composed of 25 ± 2%, 22 ± 3%, 30 ±
3%, and 22 ± 3% "-helix, $-sheet, $-turn, and random
structures, respectively. These data are comparable to the
lyophilized sample’s content of 28 ± 2%, 20 ± 5%, 34 ± 4%,
and 18 ± 4%, respectively, for similar secondary structural
elements.
Enzyme Solution. The amide I peak shifted slightly from
1648 cm−1 for the dried MicroglassifiedTM powder to 1651–
1653 cm−1 for the rehydrated samples. The secondary struc-
ture of rehydrated lysozyme that had been MicroglassifiedTM
in n-pentanol, n-octanol, or n-decanol was comparable to each
other, to the control (Table 3), as well as to previously published
values for lysozyme solution39,42 ("-helix: 40%–45%; $-sheet:
19%–41%; $-turn: 19%–32%; random: 0%–14%). Rehydrated
lysozyme that had been MicroglassifiedTM in triacetin or butyl
lactate demonstrated significantly higher (p < 0.05) $-sheet
content of 36 ± 7% and 30 ± 5%, respectively, as compared
with samples MicroglassifiedTM in pentanol (22 ± 5%) or the
control (23± 5%). It was also found that the increase in $-sheet
content in these samples was accompanied by a decrease in
$-turns and random structures, as compared with other sam-
ples or the control.
-Chymotrypsin
MicroglassifiedTM Powder. The peak center of the amide I re-
gion of the dried MicroglassifiedTM and control (lyophilized)
"-chymotrypsin was located at 1635 cm−1 indicating a major
presence of $-sheet. It was found that the secondary structure
of the MicroglassifiedTM "-chymotrypsin, with the exception of
those MicroglassifiedTM in triacetin, was comparable to that of
the control (Table 2), and previously published values for the
lyophilized formulation39,40 ("-helix: 13%–19%; $-sheet: 30%–
59%; $-turn: 19%–41%; random: 9%–14%). As a representative
example, "-chymotrypsin MicroglassifiedTM in n-pentanol con-
tained 54 ± 4% $-sheet and 18 ± 3% "-helix, which was compa-
rable to the 58 ± 4% $-sheet and 14 ± 2% "-helix of the control.
Samples MicroglassifiedTM in triacetin demonstrated a signif-
icant increase (p < 0.05) in "-helix (24 ± 2%) largely at the
expense of lower content of $-sheet (49 ± 2%) and $-turn (17 ±
3%), as compared with samplesMicroglassifiedTM in n-pentanol
or the control.
Enzyme Solution. The amide I peak center continued to occur
at 1634–1637 cm−1 indicating that the molecule was still pre-
dominantly composed of $-sheet. The overall secondary struc-
ture of the rehydrated samples that had beenMicroglassifiedTM
in n-pentanol, n-octanol, and n-decanol were comparable to
each other, to the control samples (Table 3), as well as to
the previously published literature values for "-chymotrypsin
in solution28,40,42 ("-helix: 9%–15%; $-sheet: 47%–59%; $-
turn: 17%–30%; random: 0%–15%). In contrast, rehydrated
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Table 2. FTIR Analyses of MicroglassifiedTM Enzyme Powders
Secondary Structural Element (%)
Enzyme Solvent "-Helix $-Sheet $-Turn Random
Lysozyme n-Pentanol 25 ± 2 22 ± 3 30 ± 3 22 ± 3
n-Octanol 28 ± 4 20 ± 3 32 ± 2 19 ± 5
n-Decanol 33 ± 4 22 ± 1 29 ± 1 16 ± 4
Triacetin 30 ± 3 23 ± 3 29 ± 3 18 ± 5
Butyl lactate 32 ± 3 20 ± 2 28 ± 2 20 ± 5
Lyophilized 28 ± 2 20 ± 5 34 ± 4 18 ± 4
Literaturea 22–27 21–23 33–51b
"-Chymotrypsin n-Pentanol 18 ± 3 54 ± 4 18 ± 2 10 ± 4
n-Octanol 16 ± 4 49 ± 4 26 ± 5 9 ± 3
n-Decanol 17 ± 2 52 ± 3 21 ± 1 9 ± 1
Triacetin 24 ± 2 49 ± 2 17 ± 3 9 ± 2
Butyl lactate 16 ± 1 53 ± 2 24 ± 3 7 ± 1
Lyophilized 14 ± 2 58 ± 4 21 ± 2 7 ± 1
Literaturea 13–19 30–59 19–41c 9–14
Catalase n-Pentanol 26 ± 3 22 ± 4 11 ± 3 41 ± 4
n-Octanol 26 ± 2 16 ± 3 10 ± 4 48 ± 5
n-Decanol 25 ± 4 20 ± 2 14 ± 2 41 ± 4
Triacetin 20 ± 3 23 ± 4 16 ± 4 37 ± 3
Butyl lactate 23 ± 4 26 ± 5 16 ± 2 34 ± 3
Lyophilized 26 ± 2 17 ± 3 10 ± 3 46 ± 4
Literaturea 25 19 56b
HRP n-Pentanol 40 ± 4 29 ± 2 20 ± 3 11 ± 4
n-Octanol 42 ± 3 36 ± 5 16 ± 3 6 ± 2
n-Decanol 43 ± 5 36 ± 2 14 ± 2 7 ± 3
Triacetin 38 ± 2 39 ± 4 21 ± 1 2 ± 1
Butyl lactate 27 ± 5 19 ± 6 15 ± 1 36 ± 5
Lyophilized 43 ± 4 30 ± 3 9 ± 2 18 ± 5
Literaturea 32–40 22–24
aThe literature values have been taken from Refs. 38–41.
bSum of random coils, $-turns, and other undefined contents.
cSum of $-turns, intermolecular $-sheets, and undefined contents.
samples obtained after MicroglassificationTM in triacetin or
butyl lactate demonstrated a significantly higher (p < 0.05)
content of "-helix (17 ± 4% and 27 ± 3%, respectively), as com-
pared to the rehydrated "-chymotrypsin samples that had been
MicroglassifiedTM in n-pentanol ("-helix: 10± 3%) or the control
("-helix: 11± 3%). The content of $-turn and random structures
among all rehydrated samples was comparable.
Catalase
MicroglassifiedTM Powder
The amide I peak center of all MicroglassifiedTM and control
(lyophilized) catalase samples occurred at 1638 cm−1 indicat-
ing a major presence of random structures in the molecule.
Overall, the secondary structure of catalase MicroglassifiedTM
in n-pentanol, n-decanol, and n-octanol was similar to the con-
trol (Table 2), and to a previously published study on lyophilized
catalase40 ("-helix: 25%; $-sheet: 19%; others: 56%). As a rep-
resentative example, catalase MicroglassifiedTM in n-pentanol
was composed of 26 ± 3%, 22 ± 4%, 11 ± 3%, and 41 ± 4% "-
helix, $-sheet, $-turn, and random type structures, which was
comparable to control’s content of 26 ± 2%, 17 ± 2%, 10 ±
3%, and 46 ± 4% of these secondary structural elements, re-
spectively. However, the random structure content of catalase
MicroglassifiedTM in triacetin (37 ± 3%) or butyl lactate (34 ±
3%) was significantly less (p < 0.05) than that of the control
samples.
Enzyme Solution. The amide I peak center for all rehydrated
samples occurred at 1642 cm−1 indicating that random struc-
tures were still the major constituents in the molecule. The
overall secondary structure of the rehydrated samples pre-
viously MicroglassifiedTM in n-pentanol, n-octanol, n-decanol,
and butyl lactate (Table 3) were comparable to each other, to
the control, and to previously published values for catalase in
solution40,43 ("-helix: 25%–26%; $-sheet: 12%–19%; others 55%–
63%). On the other hand, samples that were MicroglassifiedTM
in triacetin demonstrated a significantly higher (p < 0.05)
content of random structures (47 ± 3%) at the expense of $-
turn (14 ± 2%) as compared with the samples that had been
MicroglassifiedTM in n-pentanol ($-turn: 19 ± 5%; random: 35
± 4%) or the control ($-turn: 18 ± 3%; random: 40 ± 5%).
Horseradish Peroxidase
MicroglassifiedTM Powder. The peak center of the amide I re-
gion of the dried MicroglassifiedTM and control (lyophilized)
HRP samples occurred at 1646 cm−1 indicating a major pres-
ence of "-helix in these samples. The overall secondary struc-
ture of the MicroglassifiedTM HRP, with the exception of HRP
MicroglassifiedTM in butyl lactate, was similar to that of the
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Table 3. FTIR Analyses of Rehydrated MicroglassifiedTM Enzyme Solutions
Secondary Structural Element (%)
Enzyme Solvent "-Helix $-Sheet $-Turn Random
Lysozyme n-Pentanol 39 ± 4 22 ± 5 26 ± 4 15 ± 2
n-Octanol 42 ± 7 25 ± 7 20 ± 2 12 ± 4
n-Decanol 42 ± 3 22 ± 4 15 ± 4 16 ± 3
Triacetin 40 ± 5 36 ± 7 13 ± 4 10 ± 5
Butyl lactate 41 ± 5 34 ± 5 16 ± 2 9 ± 3
Lyophilized 41 ± 4 23 ± 5 23 ± 3 12 ± 2
Literaturea 40–45 19–41 19–32 0–14
"-Chymotrypsin n-Pentanol 10 ± 3 48 ± 6 27 ± 2 15 ± 3
n-Octanol 12 ± 4 43 ± 6 25 ± 6 12 ± 2
n-Decanol 13 ± 3 50 ± 5 27 ± 4 10 ± 4
Triacetin 17 ± 4 44 ± 3 25 ± 5 14 ± 5
Butyl lactate 27 ± 3 40 ± 7 18 ± 2 12 ± 4
Lyophilized 11 ± 3 50 ± 6 25 ± 3 14 ± 2
Literaturea 9–15 47–59 17–30 0–15
Catalase n-Pentanol 26 ± 3 20 ± 4 19 ± 5 35 ± 4
n-Octanol 23 ± 5 22 ± 5 20 ± 6 36 ± 5
n-Decanol 21 ± 3 18 ± 6 20 ± 4 41 ± 3
Triacetin 23 ± 5 15 ± 5 14 ± 2 47 ± 3
Butyl lactate 23 ± 6 22 ± 7 24 ± 4 31 ± 5
Lyophilized 26 ± 2 20 ± 3 18 ± 3 40 ± 5
Literaturea 25–33 12–19 55–63b
HRP n-Pentanol 49 ± 3 8 ± 3 24 ± 3 19 ± 3
n-Octanol 43 ± 5 12 ± 4 19 ± 4 26 ± 5
n-Decanol 45 ± 4 12 ± 3 22 ± 3 20 ± 4
Triacetin 57 ± 7 9 ± 4 12 ± 5 21 ± 4
Butyl lactate 41 ± 6 10 ± 5 26 ± 2 22 ± 6
Lyophilized 48 ± 4 7 ± 2 24 ± 1 20 ± 3
Literaturea 45–51 2–11 38–47b
aThe literature values have been taken from Refs. 28 and 39–43
bSum of $-turns, intermolecular $-sheets, and random contents.
control (Table 2), and previously published literature values
for the lyophilized formulation39,41 ("-helix: 32%–40%; $-sheet:
22%–24%; others 37%–46%). Thus, HRP MicroglassifiedTM in
n-pentanol was composed of 40 ± 4%, 29 ± 2%, 20 ± 3%, and
11 ± 4% "-helix, $-sheet, $-turn, and random structures, which
was comparable to control’s content of 43 ± 4%, 30 ± 3%, 9
± 2%, and 18 ± 5% of these structural elements, respectively.
However, HRPMicroglassifiedTM in butyl lactate demonstrated
a significant (p < 0.01) twofold to threefold increase in ran-
dom structures reduced (p < 0.05) as compared with HRP
MicroglassifiedTM in n-pentanol or the control.
Enzyme Solution. For the rehydrated HRP samples, the
amide I peak center showed a major shift from 1645 cm−1 upon
MicroglassificationTM to 1650–1652 cm−1 after rehydration.
The overall secondary structure of the rehydrated HRP sam-
ples MicroglassifiedTM in any of the solvents (Table 3), with the
exception of triacetin, was comparable to each other, to the con-
trol, and to previously published values for HRP in solution39,41
("-helix: 45%–51%; $-sheet: 2%–11%; others 38%–47%). Re-
hydrated HRP that had been MicroglassifiedTM in triacetin
demonstrated a significantly higher (p < 0.05) content of "-
helix (57 ± 7%) and a lower content of $-turn (12 ± 5%) as com-
pared with rehydrated samples that were MicroglassifiedTM in
n-pentanol ("-helix: 49 ± 3%; $-turn: 24 ± 3%), or the control
("-helix: 48 ± 4%; $-turn: 24 ± 1%). The content of $-sheet and
random structures among all rehydrated samples were compa-
rable.
Accelerated Storage Test Results
In order to gain an early evaluation of the stability of the
MicroglassifiedTM enzyme powders in these initial studies, we
measured if and to what extent there were any changes in enzy-
matic activity and secondary structure ofMicroglassifiedTM and
lyophilized lysozyme over a 3-month period at just one elevated
temperature of 40◦C.
Lysozyme Activity upon Stress Storage
The enzymatic activity of the MicroglassifiedTM and lyophilized
lysozyme (control) samples decreased significantly (p < 0.01)
(by ∼33%) from 46,560 ± 2736 and 49,440 ± 6702 units/mg at
month 0, to 30,000 ± 1385 and 30,600 ± 3600 units/mg, respec-
tively, after incubation at 40◦C for 1 month (Fig. 5). However,
upon further incubation, the MicroglassifiedTM and lyophilized
samples showed minimal changes in their enzymatic activity.
The activities of the MicroglassifiedTM and lyophilized samples
were 30,215 ± 5438 and 31,060 ± 4327 units/mg after month
2, and 26,780 ± 3018 and 27,225 ± 2910 units/mg after month
3, respectively. It is noteworthy that the enzymatic activities of
the MicroglassifiedTM and lyophilized samples were compara-
ble at all time points.
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Figure 5. Accelerated storage test results showed a significant reduc-
tion (**p< 0.01) of∼33% in the enzymatic activity of MicroglassifiedTM
and lyophilized lysozyme samples after 1 month of incubation at 40◦C,
after which the activity of both sample types remained comparable.
Note that the activity of the MicroglassifiedTM and lyophilized sample
was comparable throughout the test period.
Changes in Secondary Structure
As shown in Table 4, FTIR analyses of the MicroglassifiedTM
and lyophilized lysozyme powders incubated at 40◦C for 3
months showed major changes in the structure of the enzyme.
After 1 month of incubation, the content of $-sheet in the
samples decreased significantly (p < 0.05) from 22 ± 3% and
20 ± 5% to 14 ± 4% and 13 ± 2% in the MicroglassifiedTM
and lyophilized samples, respectively. The decrease in the $-
sheet content was accompanied by a significant (p < 0.05) in-
crease in the content of random structures, which increased
from 22 ± 3% and 18 ± 4% to 35 ± 5% and 27 ± 4% in the
MicroglassifiedTM and lyophilized samples, respectively, during
the same time period. Thereafter, minimal structural changes
in the powders, both MicroglassifiedTM and lyophilized, were
observed. It was also observed that throughout the 3-month
storage period, the content of "-helix and $-turn structures, in
both the MicroglassifiedTM and lyophilized samples, remained
nearly identical.
DISCUSSION
The main objectives of this work were to test the feasibility
of MicroglassificationTM to controllably dehydrate enzymes in
a series of dehydrating solvents, and evaluate the changes in
enzyme structure and function upon rehydration. Using our
signature micropipet manipulation technique, it was found
that butyl lactate and n-pentanol had higher dehydration
rates than n-octanol, n-decanol, or triacetin. Enzymatic ac-
tivity assays showed that catalase, lysozyme, "-chymotrypsin,
and HRP that had been MicroglassifiedTM in n-pentanol, re-
tained an average of 93%, 94%, 96%, and 98% of their
activity upon rehydration, respectively. FTIR analyses
indicated that all the enzymes underwent significant structural
rearrangement upon MicroglassificationTM. Upon reconstitu-
tion in buffer, the enzymes MicroglassifiedTM in n-pentanol,
n-decanol, or n-octanol generally reverted to a native-like
conformation, whereas the enzymes MicroglassifiedTM in tri-
acetin or butyl lactate demonstrated structural deviations from
the native conformation. Accelerated storage tests for both
MicroglassifiedTM and lyophilized lysozyme showed that al-
though the enzymatic activity reduced significantly after in-
cubation at 40◦C for 3 months, the activities of both for-
mulations were comparable to each other throughout the
test period. Taken together, these results demonstrate that
MicroglassificationTM is an attractive method to successfully
and conveniently dehydrate enzymes for long-term preserva-
tion.
The removal of water from an aqueous protein micro-
droplet immersed in an organic drying medium depends on
the droplet’s dissolution rate, and is proportional to the solubil-
ity and diffusion of water in that drying solvent.44 Water dis-
solution is primarily driven by enthalpic and entropic effects
arising from the difference in water activity (aw) between the
two phases. In our earlier work, we have established that wa-
ter continues to dissolve into the organic phase until aw of both
phases are in equilibrium, resulting in protein solidification in
the form of a MicroglassifiedTM bead.18,19 As shown in Table 1
and Figure 2, water dissolution rates generally increased with
increasing solubility, and can be successfully modeled by the
Epstein–Plesset equation44:
dR
dt
= −DC3(1− f )
D
(
1
R
+ 1√
BDt
)
where R is the droplet radius, D is the diffusion coefficient of
water in the surrounding medium, Cs is water solubility, D is
droplet density, and t is time.
The Epstein–Plesset equation and our micropipet assay on
single microdroplets of pure water23 and protein solutions18,19
provide fundamental guiding principles for dehydration proce-
dures. The mass transfer rate of water (dR/dt) is dependent
on the product of water solubility (Cs) and its diffusion coef-
ficient (D). Water can form a hydrogen bond with the (–OH)
group of n-octanol, and this hydrogen bonding between a so-
lute and a solvent decreases D by an order of magnitude and
slows the dissolution process.23 Therefore, for similar solubil-
ities, a faster diffusion rate leads to a greater overall mass
transfer rate of water out of the microdroplet. Similarly, a
Table 4. Accelerated Stability Test—Lysozyme Secondary Structure (%)
MicroglassifiedTM Lysozyme Lyophilized Lysozyme
Month 0 1 2 3 0 1 2 3
"-Helix 25 ± 2 23 ± 3 21 ± 5 26 ± 3 28 ± 2 25 ± 3 26 ± 4 24 ± 4
$-Sheet 22 ± 3 14 ± 4 11 ± 2 10 ± 3 20 ± 5 13 ± 2 11 ± 3 11 ± 2
$-Turn 30 ± 3 27 ± 2 29 ± 3 25 ± 4 34 ± 4 35 ± 2 31 ± 4 33 ± 2
Random 22 ± 3 35 ± 5 38 ± 4 39 ± 5 18 ± 4 27 ± 4 32 ± 5 31 ± 2
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drying solvent that has greater solubility for water increases
the dissolution rate, thereby reducing the time required for
equilibration. Our results showed that solvents with higher di-
electric constant (g) also demonstrated a higher water solubility
limit (Table 1). A high dielectric solvent, because of its greater
charge carrying capacity, and therefore a greater ability to of-
fer a transition-state stabilization, weakens the electrostatic
forces between polar residues and water.45 Therefore, because
of the concomitant contributions from several factors including
hydrogen bonding, diffusivity, and dielectric properties, water
solubility and dissolution rate increased in the order: n-decanol
< n-octanol < triacetin < n-pentanol < butyl lactate (Fig. 2).
Following the vortex procedure to produce water-in-oil emul-
sions fromwhich theMicroglassifiedTM beads formed, size anal-
yses showed that the particle size distributions of all enzyme
beads were quite similar to each other (Fig. 3). The large
differences in molecular weights of the enzymes—lysozyme
(14 kDa) is approximately twofold and threefold smaller than
"-chymotrypsin (25 kDa) and HRP (44 kDa), and ∼18-fold
smaller than catalase (250 kDa)—was inconsequential, and
the MicroglassifiedTM bead size was influenced by physical fac-
tors, such as enzyme concentration, and vortex speed that
determined the initial (water-in-oil) microdroplet size. Nev-
ertheless, molecular weight may have had some influence on
the retention of enzymatic activity. Small, single-domain pro-
teins usually require extreme conditions to unfold, whereas
in larger, multi-domain proteins, modification of a few weak
links, even under gentle conditions, can be sufficient to initi-
ate unfolding and aggregation.46 Thus, HRP MicroglassifiedTM
in triacetin or butyl lactate retained only 36% and 48% ac-
tivity upon rehydration, whereas lysozyme MicroglassifiedTM
in these solvents retained 82% and 79% activity, respectively,
which is in agreement with lysozyme being a relatively stable
protein.47
Overall our results demonstrate that MicroglassificationTM
preserves the selective structure-function relationship of
an enzyme while gently dehydrating the molecule. En-
zymes MicroglassifiedTM in primary alkyl-alcohols, espe-
cially n-pentanol, demonstrated comparable enzymatic activ-
ity to the control (lyophilized formulation) upon rehydration
(Fig. 4), and maintained a secondary conformation that was
similar to the native enzyme (Table 3). In contrast, en-
zymes MicroglassifiedTM in triacetin or butyl lactate generally
demonstrated lower activity upon reconstitution than those
MicroglassifiedTM in other solvents (also shown in Fig. 4). While
evaluating overall changes in the whole molecule does little
to help understand the effects these solvents might have on
structure of the enzyme pocket, we may speculate as to some
possible effects, for later examination. Triacetin has a lower
dielectric constant than the alcohols. The dielectric constant of
pentanol is 15.1, whereas that of triacetin is 7.1 (Table 1). It
may be possible that the lower dielectric constant of triacetin
shields the weakening of electrostatic interactions between
the polar residues on the protein’s surface and water, which
could have enabled undesirable irreversible structural reor-
ganization upon MicroglassificationTM, particularly for bulky
enzymes, thus affecting their activity either directly in the en-
zyme pocket or allosterically within the protein. In contrast
to triacetin, butyl lactate showed a much greater hydrophilic
character as evidenced by its higher water solubility limit; how-
ever, the activities of the rehydrated enzymesMicroglassifiedTM
in this solvent were the lowest among all solvents. In the
case of MicroglassifiedTM HRP, it showed significantly altered
conformation in the solid-state as compared to the control
(Table 2), and despite the restoration of overall secondary struc-
ture upon rehydration, it expressed significantly lower activity
than the control. Although speculative, these results suggest
that the deleterious effect of active-site disruption due to a
drastic change in hydration environmentmay not be completely
reversible upon rehydration.
FTIR analyses of the enzyme secondary structure also
showed that the enzymes underwent structural rearrangement
upon MicroglassificationTM (Tables 2 and 3). Because large
amounts of water of hydration were removed, such behavior
is expected for the dehydrated samples. Specifically, it was
found that the content of $-sheet structures increased, and
this was accompanied by a decrease in the content of "-helix
structures, although the magnitude of this transformation var-
ied among different enzymes. For instance, $-sheet content of
catalase tripled upon dehydration, from 22 ± 3% to 66 ± 4%,
whereas its "-helix content decreased from 26 ± 2% to 16 ±
3%. Water molecules can form hydrogen bonds more easily
with the (C=O) groups of the peptide backbone that consti-
tutes the "-helix but not with the $-sheets48; hence, water
loss upon dehydration disrupts "-helix structure more than
$-sheet. These results are consistent with other reports on
structural changes during lyophilization of insulin and poly(L-
lysine), where a similar increase in $-sheet was observedmostly
at the expense of "-helix.48 Nevertheless, it should be noted
that the changes in enzyme conformation were largely re-
versible, as the secondary structure of the enzymes before and
after MicroglassificationTM, and subsequent rehydration, were
comparable.
Accelerated storage test results showed that enzymatic ac-
tivity of MicroglassifiedTM and lyophilized lysozyme samples
reduced by almost one-third after 1 month of incubation at
40◦C (Fig. 5). The reduction in the enzymatic activity can be
attributed to the structural changes in these molecules during
storage, in particular, ∼50% loss of $-sheet observed in both
samples (Table 4). The active-site of lysozyme is located within
a cleft formed by "- and $-domain, wherein the former domain
consists primarily of "-helices and the latter domain consists of
three $-sheets.49 Therefore, the significant loss of $-sheet under
the stressed storage conditions likely induced irreversible mod-
ifications in the enzyme’s active site that resulted in reduced
activity.
CONCLUSIONS
The results of this study demonstrate the feasibility of
MicroglassificationTM to rapidly and controllably dehydrate a
series of common enzymes while largely preserving their struc-
ture and enzymatic activity. It was found that the primary
alkyl-alcohols, in particular n-pentanol, were the most opti-
mal solvents for enzyme dehydration. FTIR analyses of the en-
zyme secondary structure showed that, as expected, all the en-
zymes underwent structural rearrangements upon dehydration
by MicroglassificationTM and subsequent drying. Most promi-
nently, this resulted in "-helix to $-sheet type transformation
as the enzymes solidified from solution into a MicroglassifiedTM
state. The changes in enzyme secondary structure were essen-
tially reversible as indicated by reorganization to a near native-
like conformation upon rehydration. Accelerated storage test
results showed that the enzymatic activity of MicroglassifiedTM
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and lyophilized lysozyme reduced significantly upon storage
at 40◦C; however, their activities were comparable to each
other. Thus, MicroglassificationTM can have direct applica-
tion for the preservation of enzymes, proteins, and other bio-
macromolecules. We envision that this method can also be used
as a formulation technique to develop high-concentration in-
jectable biotherapeutics in the form of micro- and nano-sized
MicroglassifiedTM beads, including encapsulation in slow re-
lease polymer formulations.
ACKNOWLEDGMENTS
The authors would like to thank Mr. Ryan Denkewicz for assis-
tance with FTIR spectra analyses.
This work was supported by grant no. IIP-0848968 from the
National Science Foundation.
REFERENCES
1. Carpenter JF, Pikal MJ, Chang BS, Randolph TW. 1997. Rational
design of stable lyophilized protein formulations: Some practical advice.
Pharm Res 14(8):969–975.
2. Pikal MJ. 1999. Mechanisms of protein stabilization during freeze-
drying and storage: The relative importance of thermodynamic stabi-
lization and glassy state relaxation dynamics. Drugs PharmSci 96:161–
198.
3. Carpenter JF, Izutsu K-i, Randolph TW. 2004. Freezing-and drying-
induced perturbations of protein structure and mechanisms of pro-
tein protection by stabilizing additives. Drugs Pharm Sci 137:147–
186.
4. Gidalevitz D, Huang Z, Rice SA. 1999. Protein folding at the air–
water interface studied with X-ray reflectivity. Proc Natl Acad Sci USA
96(6):2608–2611.
5. Wang W. 1999. Instability, stabilization, and formulation of liquid
protein pharmaceuticals. Int J Pharm 185(2):129–188.
6. Carpenter J, Prestrelski S, Arakawa T. 1993. Separation of freezing-
and drying-induced denaturation of lyophilized proteins using stress-
specific stabilization: I. Enzyme activity and calorimetric studies. Arch
Biochem Biophys 303(2):456–464.
7. Abdul-Fattah AM, Kalonia DS, Pikal MJ. 2007. The challenge of
drying method selection for protein pharmaceuticals: Product quality
implications. J Pharm Sci 96(8):1886–1916.
8. Liao Y-H, BrownMB, Quader A, Martin GP. 2002. Protective mecha-
nism of stabilizing excipients against dehydration in the freeze-drying
of proteins. Pharm Res 19(12):1854–1861.
9. Anandharamakrishnan C, Rielly C, Stapley A. 2007. Effects of pro-
cess variables on the denaturation of whey proteins during spray dry-
ing. Drying Technol 25(5):799–807.
10. Anandharamakrishnan C, Rielly CD, Stapley A. 2008. Loss
of solubility of "-lactalbumin and $-lactoglobulin during the
spray drying of whey proteins. LWT-Food Sci Techol 41(2):270–
277.
11. Capolongo A, Barresi AA, Rovero G. 2003. Freeze-drying of lignin
peroxidase: Influence of lyoprotectants on enzyme activity and stability.
J Chem Technol Biotechnol 78(1):56–63.
12. Carpenter JF, Chang BS, Garzon-Rodriguez W, Randolph TW.
2002. Rational design of stable lyophilized protein formulations: The-
ory and practice. In Rational design of stable protein formulations;
Carpenter JF, ManningMC, Eds. New York: Kluwer Academic/Plenum
Publishers, pp 109–133.
13. Webb SD, Golledge SL, Cleland JL, Carpenter JF, Randolph
TW. 2002. Surface adsorption of recombinant human interferon-
( in lyophilized and spray-lyophilized formulations. J Pharm Sci
91(6):1474–1487.
14. Webb SD, Cleland JL, Carpenter JF, Randolph TW. 2003. Effects
of annealing lyophilized and spray-lyophilized formulations of recom-
binant human interferon-(. J Pharm Sci 92(4):715–729.
15. Maltesen MJ, van de Weert M. 2008. Drying methods for protein
pharmaceuticals. Drug Discov Today Technol 5(2):e81–e88.
16. Wang W. 2005. Protein aggregation and its inhibition in biophar-
maceutics. Int J Pharm 289(1):1–30.
17. Iyer PV, Ananthanarayan L. 2008. Enzyme stability and
stabilization—Aqueous and non-aqueous environment. Process
Biochem 43(10):1019–1032.
18. Aniket, Gaul DA, Rickard DL, Needham D. 2014.
MicroglassificationTM: A novel technique for protein dehydration.
J Pharm Sci 103(3):810–820.
19. Rickard DL, Duncan PB, Needham D. 2010. Hydration potential of
lysozyme: Protein dehydration using a single microparticle technique.
Biophys J 98(6):1075–1084.
20. Mohrig JR, Hammond CN, Schatz PF. 2006. Techniques in organic
chemistry. 2nd ed. New York: WH Freeman & Company.
21. Segatin N, Klofutar C. 2004. Thermodynamics of the solubility of
water in 1-hexanol, 1-octanol, 1-decanol, and cyclohexanol. Monatsh
fu¨r Chemie/Chem Mon 135(3):241–248.
22. Duncan PB, Needham D. 2004. Test of the Epstein–Plesset model
for gas microparticle dissolution in aqueous media: Effect of surface
tension and gas undersaturation in solution. Langmuir 20(7):2567–
2578.
23. Su JT, Duncan PB, Momaya A, Jutila A, Needham D. 2010. The
effect of hydrogen bonding on the diffusion of water in n-alkanes and
n-alcohols measured with a novel single microdroplet method. J Chem
Phys 132:044506.
24. Smolelis A, Hartsell S. 1949. The determination of lysozyme. J
Bacteriol 58(6):731–736.
25. Hummel BC. 1959. A modified spectrophotometric determina-
tion of chymotrypsin, trypsin, and thrombin. Can J Biochem Physiol
37(12):1393–1399.
26. Beers RF, Sizer IW. 1952. A spectrophotometric method for mea-
suring the breakdown of hydrogen peroxide by catalase. J Biol Chem
195(1):133–140.
27. Chance B, Maehly A. 1955. Assay of catalases and peroxidases.
Methods Enzymol 2:764–775.
28. Dong A, Huang P, CaugheyWS. 1990. Protein secondary structures
in water from second-derivative amide I infrared spectra. Biochemistry
29(13):3303–3308.
29. Byler DM, Susi H. 1986. Examination of the secondary struc-
ture of proteins by deconvolved FTIR spectra. Biopolymers 25(3):469–
487.
30. Kommanaboyina B, Rhodes C. 1999. Trends in stability testing,
with emphasis on stability during distribution and storage. Drug Dev
Ind Pharm 25(7):857–868.
31. Bajaj S, Singla D, Sakhuja N. 2012. Stability testing of pharmaceu-
tical products. J Appl Pharm Sci 2(3).
32. Bowen M, Armstrong N, Maa Yf. 2012. Investigating high-
concentration monoclonal antibody powder suspension in nonaque-
ous suspension vehicles for subcutaneous injection. J Pharm Sci
101(12):4433–4443.
33. Bond MD, Panek ME, Zhang Z, Wang D, Mehndiratta P, Zhao H,
Gunton K, Ni A, Nedved ML, Burman S. 2010. Evaluation of a dual-
wavelength size exclusion HPLC method with improved sensitivity to
detect protein aggregates and its use to better characterize degradation
pathways of an IgG1 monoclonal antibody. J Pharm Sci 99(6):2582–
2597.
34. D’Aprano A, Donato DI, Agrigento V. 1982. Molecular association
in water–isomeric pentanol mixtures at 25◦ C. J Solut Chem 11(4):259–
269.
35. Stephenson R, Stuart J, Tabak M. 1984. Mutual solubility of water
and aliphatic alcohols. J Chem Eng Data 29(3):287–290.
36. Stephenson R, Stuart J. 1986. Mutual binary solubilities: Water-
alcohols and water-esters. J Chem Eng Data 31(1):56–70.
DOI 10.1002/jps.24279 Aniket et al., JOURNAL OF PHARMACEUTICAL SCIENCES
12 RESEARCH ARTICLE – Pharmaceutical Biotechnology
37. Lide DR. 2004. CRC handbook of chemistry and physics: A ready-
reference book of chemical and physical data. 71st ed. Boca Raton,
Florida: CRC Press.
38. Fu K, Griebenow K, Hsieh L, Klibanov AM, Langera R. 1999.
FTIR characterization of the secondary structure of proteins encap-
sulated within PLGA microspheres. J Control Release 58(3):357–
366.
39. Montalvo BL, Pacheco Y, Sosa BA, Ve´lez D, Sa´nchez G, Griebenow
K. 2008. Formation of spherical protein nanoparticles without impact-
ing protein integrity. Nanotechnology 19(46):465103.
40. Lee SL, Hafeman AE, Debenedetti PG, Pethica BA, Moore
DJ. 2006. Solid-state stabilization of "-chymotrypsin and cata-
lase with carbohydrates. Ind Eng Chem Res 45(14):5134–
5147.
41. Al-AzzamW, Pastrana EA, Ferrer Y, Huang Q, Schweitzer-Stenner
R, Griebenow K. 2002. Structure of poly (ethylene glycol)-modified
horseradish peroxidase in organic solvents: Infrared amide I spectral
changes upon protein dehydration are largely caused by protein struc-
tural changes and not by water removal per se. Biophys J 83(6):3637–
3651.
42. Sachdeva A, Cai S. 2009. Structural differences of proteins between
solution state and solid state probed by attenuated total reflection
Fourier transform infrared spectroscopy. Appl Spectrosc 63(4):458–464.
43. Murthy M, Reid III TJ, Sicignano A, Tanaka N, Rossmann MG.
1981. Structure of beef liver catalase. J Mol Biol 152(2):465–499.
44. Epstein P, PlessetM. 1950. On the stability of gas bubbles in liquid–
gas solutions. J Chem Phys 18(11):1505–1509.
45. Clark DS. 2004. Characteristics of nearly dry enzymes in organic
solvents: Implications for biocatalysis in the absence of water. Philos
Trans R Soci Lond Ser B Biol Sci 359(1448):1299–1307.
46. Frokjaer S, Otzen DE. 2005. Protein drug stability: A formulation
challenge. Nat Revi Drug Discov 4(4):298–306.
47. Go M. 1983. Modular structural units, exons, and function in
chicken lysozyme. Proc Natl Acad Sci USA 80(7):1964–1968.
48. Griebenow K, Klibanov AM. 1995. Lyophilization-induced re-
versible changes in the secondary structure of proteins. Proc Natl Acad
Sci USA 92(24):10969–10976.
49. Kubiak-Ossowska K, Mulheran PA. 2010. Mechanism of hen egg
white lysozyme adsorption on a charged solid surface. Langmuir
26(20):15954–15965.
Aniket et al., JOURNAL OF PHARMACEUTICAL SCIENCES DOI 10.1002/jps.24279
